Skip to content
Screener

Phibro Animal Health PAHC Operating Cash Flow

Operating Cash Flow at other companies

Merck & Co. logo
Merck & Co.MRK
$5.37B+63.1%
Zoetis logo
ZoetisZTS
$655M+8.3%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$277M+16.9%
Neogen logo
NeogenNEOG
$22.7M+16.7%
Balchem logo
BalchemBCPC
$40.06M+9.9%
Petco Health and Wellness Company, Inc. logo
Petco Health and Wellness Company, Inc.WOOF
-$30.97M-100%

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.44B+34.1%
Enterprise value$1.42B+33.1%
P/E15.1×-7.1×
P/S+0.1×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Phibro Animal Health’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:25 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056280
For the Periods Ended March 31Nine Months / 2026Nine Months / 2025
Other assets7453,809
Accounts payable(6,816)42,936
Accrued expenses and other liabilities(2,302)21,043
Net cash provided by operating activities44,86058,852
INVESTING ACTIVITIES
Purchases of short-term investments(37,026)(10,000)
Maturities of short-term investments23,50444,000
Capital expenditures(40,219)(25,151)

Item 1. Financial Statements (unaudited)

FAQ

What is Phibro Animal Health's operating cash flow?
Phibro Animal Health (PAHC) reported operating cash flow of $16.21M in Q1 2026.
How has Phibro Animal Health's operating cash flow changed year-over-year?
Phibro Animal Health's operating cash flow decreased by 62.4% year-over-year, from $43.15M to $16.21M.
What is the long-term trend for Phibro Animal Health's operating cash flow?
Over 3 years (2022 to 2025), Phibro Animal Health's operating cash flow has grown at a 36.3% compound annual growth rate (CAGR), from $31.65M to $80.12M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Phibro Animal Health's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude